At undergraduate level, Una’s main contribution has been to develop and deliver the 5^th year Therapeutics teaching programme and Prescribers’ Licence (previously the Therapeutics OSCE) as module lead for prescribing in the MBChB . The expertise gained was used to develop the National Prescribing Assessment which the College has now adopted. Una is lead for the  Hypertension module in the postgraduate MSc in cardiovascular medicine with responsibility for programme design and recruitment of speakers. She is responsible for Clinical Pharmacology training in the West Midlands as Chair of the Specialist Training Committee.

Her national contribution to Clinical Pharmacology has been recognised by a Fellowship from the British Pharmacological Society in 2012. She is External Examiner for Therapeutics in University of Cork.

Una’s area of expertise is in hypertension and her contribution to the field has been recognised by a Fellowship of the British Hypertension Society. Her research has had a major impact on how hypertensive patients are diagnosed and treated both in the UK and Internationally.  Highlights include:

• She has investigated ethnic differences in blood pressure measured by ambulatory, clinic and home monitoring.
• Her clinical experience in ambulatory monitoring (ABPM) informed the design and interpretation of a systematic review published in the BMJ and subsequent cost effective analysis published in the Lancet which led to a major change in NICE guidelines in 2011 (NICE clinical guideline 127).
• Her delivery of an ABPM service was used as a template in a subsequent NICE implementation guideline (NICE clinical guideline 127) and my team developed an instruction video on ABPM on behalf of the British Hypertension Society.
  • She has published several papers relevant to the day to day management of hypertension for example on the relationship between inter-arm blood pressure measurements to ambulatory readings, the problem of adverse drug reactions in antihypertensive treatment in patients aged >80 years and the worrying trend of prescription of inappropriate (and potentially teratogenic) antihypertensive agents to women of child bearing age.

Equalities

Following the publication of “Women in Academic Medicine” by the BMA (2008), Una took a lead role in a Women in Academic Medicine (WAMs) Steering Group established in MDS, subsequently becoming the group’s Chair.  Their programme includes workshops tailored to the needs of female academics, a College wide mentoring scheme and events and networking opportunities. More systemic barriers have also been addressed and she has been successful in raising issues and proposing solutions at senior levels: a scheme to “buy out” teaching or administration for those returning from maternity/adoption leave so individuals can focus on their research is now University policy;  WAMs is currently piloting a scheme which nominates MDS Leads to advise individuals about promotions and to give support where funding for maternity leave is complex.

Una has been an effective advocate for Athena SWAN at Birmingham. She led the MDS self-assessment team (SAT) which achieved a College, first Silver Award in 2014 and also Chair’s the University’s SAT. Una has ensured the lessons learnt and best practices from MDS have been disseminated across STEMM disciplines and has actively supported Schools to achieve awards to date. The Athena SWAN work has had a wider impact across the University, which in 2014, launched an initiative “Advancing Equality in Employment” (AEiE) to address barriers across all strands of equality. As a member of the Steering Group, her  experience of diversity issues and pro-active approach were instrumental in the success of AEiE (which won the first ever Personnel Today HR Award for Equality and Inclusion).

Following the AEiE the University established a DPVC role for Equalities to build on progress. Since successfully applying for this role in September 2015 Una has overseen the development of a new Equality Scheme for 2016-2020, encouraging all students and staff to identify ‘one key change’ they would like to see; she made a successful case to the University Board for significant additional funding and champions wider equalities, for example by hosting a Stonewall Allies workshop at the University in May.

Programme Director of the NIHR/WTCRF

Una was Programme Director of the NIHR/WTCRF, a partnership between the University of Birmingham and University Hospital Birmingham Foundation Trust from 2011-2015. This is a key strategic role for the delivery of Clinical Research in the College of MDS.

1. Wood, S., Greenfield, S., Sayeed Haque, M., Martin, U., Gill, P., Mant, J., Mohammed, A.M., Heer, G., Johal, A., Kaur, R., Schwartz, C., McManus, RJ. “Patient preferences for different methods of blood pressure measurement: is ethnicity relevant?” British Journal of General Practice (In Press)
2. Sheppard, J.P., Martin, U., McManus, R.J. Diagnosis and management of resistant hypertension. Heart (In Press).

Peer reviewed Journal publications

1. Hodgkinson, J.A., Doshiaris, C., Martin, U., Mant, J., Heneghan, C., Hobbs, R., McManus, R.  Accuracy of blood pressure monitors in retail pharmacies. (2016) British Journal of General Practice 66(646):e309-14. Doi:1.3399/bjgp16X684769

2. Mant, J., McManus, R.J., Roalfe, A., Fletcher, K., Taylor, C.J., Martin, U., Virdee, S., Greenfield, S., Hobbs, F.D.R.  Randomised controlled trial of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: the PAST-BP (Prevention After Stroke – Blood Pressure) study. (2016)  British Medical Journal  Feb 24;352:i708. doi: 10.1136/bmj.i708.

3. Sheppard, J.P., Stevens, R., Gill, P.,  Martin, U., Godwin, M., Hanley, J., Heneghan, C., Hobbs, F.D.R., Mant, J.,  McKinstry, B., Myers, M., Nunan, D., Ward,  A.,Williams, B., McManus, R.J. “PRedicting Out-of-OFfice Blood Pressure in the clinic (PROOF-BP): Derivation and validation of a tool to improve the accuracy of blood pressure measurement in routine clinical practice.” (2016) Hypertension 67:941-50.     doi:10.11.1161/HYPERTENSIONAHA.115.07108

4. Sharp, A.S., Davies, J.E., Lobo, M.D., Bent, C.L., Mark, P.B., Burchell, A.E., Thackray, S.D., Martin U, et al. “Renal artery sympathetic denervation: observations from the UK experience” (2016)  Clinical Research in Cardiology 105:544-52. doi: 10.1007/s00392-015-0959-4

5. Thomas, O., Shipman, K., Day, K., Thomas, M., Martin, U., Dasgupta, I. “Prevalence         and determinants of white coat effect in a large UK hypertension clinic” 2016 Journal of Human Hypertension  30:386-91. doi: 10.1038/jhh.2015.95. 

6. Sheppard, J.P., Fletcher, B.R., Martin, U., Gill, P., Roberts, N., McManus, R.J. “Predictors of the home-clinic blood pressure difference: a systematic review and metaanalysis” 2016 American Journal of Hypertension 29:614-625. doi:10.1093/ajh/hpv

7. Hameed, A., Pucci, M., Martin, U., Watkin, R., Doshi, S.N., Freedman, J.S., Riley, P., Townend, J.N., Crowe, P., Lipkin, G.W., Dasgupta, I., “Renal denervation in patients with uncontrolled hypertension and confirmed adherence to antihypertensive medications”  (2016) The Journal of Clinical Hypertension 18:565-71. doi: 10.1111/jcj.12713

8. Martin, U., Gill, P., Wood, S., Greenfield, S.M., Sayeed Haque, M., Mant, J., Mohammed, M.A., Heer, G.,  Johal, A.,  Kaur, R., Schwartz, C., McManus, R.J. “Ethnicity and differences in clinic and ambulatory  blood pressure”. (2015) American Journal of Hypertension 28: 729-38. doi: 10.1093/ajh/hpu211

9. Sheppard, J.P., Hodgkinson, J., Riley R, Martin, U., Bayliss, S., McManus, R.J. “Prognostic significance of the morning blood pressure surge in clinical practice: a systematic review”. (2015) American Journal of Hypertension 28:30-41. doi: 10.1093/ajh/hpu104

10. Hodgkinson, J.A., Sheppard, J.P., Heneghan, C., Martin, U., Mant, J., Roberts, N., McManus, R.J. (2013), “Accuracy of ambulatory blood pressure monitors: A systematic review of validation studies.”  Journal of Hypertension 31:239-250.

11. Martin, U., Holder, R.L., Hodgkinson, J., McManus, R.J. (2013), “Inter-arm blood pressure differences compared with ambulatory monitoring:  a manifestation of the “White-Coat” effect?”  British Journal of General Practice 63:77-78 and authors response 63:237-238.

12. Wood, S.,  Martin, U., Gill, P., Greenfield, S.M., M. Haque, S., Mant, J., Mohammed, M.A.,  Coleman, J.J.,  Heer, G.,  Johal, A., Kaur, R., Schwartz, C., McManus, R.J. (2012),  “Blood Pressure in Different Ethnic Groups (BP-Eth): a mixed methods study.” BMJ Open 2:e001598.

13. Loviband, K., Jowett, S., Barton, P., Caulfield, M., Heneghan, C., Hobbs, R., Hodgkinson, J., Mant, J., Martin, U., Williams, B., Wonderling, D., McManus, R.J (2011), “Cost effectiveness of options for the diagnosis of high blood pressure in primary care: a modeling study.” Lancet 378 (9798): 1219-1230.

14. Hodgkinson, J., Mant, J., Martin, U.,  Guo, B., Hobbs, F.D.R., Deeks, J.J., Heneghan, C., Roberts, N., McManus, R.J. (2011), “  Relative effectiveness of clinic and home blood pressure monitoring compared to ambulatory blood pressure monitoring in the diagnosis of hypertension: a systematic review.” British Medical Journal 342:d3621.

15. McManus, R., Martin, U. (2010), “Differences in clinic and ambulatory measurements of blood pressure.” British Medical Journal 340:c1782.

16. Fletcher, K., Mant, J., McManus, R.J.M., Campbell, S.L., Betts, J., Taylor, C.J., Virdee, S.K., Jowett, S.M., Martin, U., Greenfield, S.M., Ford, G., Freemantle, N., Hobbs, F.D.R. (2010), “Protocol for Past BP: a randomized controlled trial of different blood pressure targets for people with a history of stroke or transient ischaemic attack (TIA) in primary care.” BMC Cardiovascular Disordors 10: 37.

17. Edwards, L., Ring, C., McIntyre, D., Martin, U, Winer JB. (2010), “Effects of essential hypertension on short latency human somatosensory-evoked potentials.” Psychophysiology 47: 323-331.

18. Butt, T.F., Branch, R.B., Beesley, L., Martin, U. (2010), “Managing hypertension in the very elderly; impact of adverse drug reactions on achieving targets.” Journal of Human Hypertension 24: 514-518.

19. Martin, A.Q., Ring, C., McIntyre, D., Edwards, L., Martin, U. (2009), “Effects of unpredictable stimulation on pain and nocioception across the cardiac cycle.” Pain 147:84-90.

20. Edwards, L., Ring, C., McIntyre, D., Winer, J.B., Martin U. (2009), “Sensory detection thresholds are modulated across the cardiac cycle: Evidence that cutaneous sensibility is greatest for systolic stimulation.” Psychophysiology 46: 252-256.

21. Boos, C.J., Martin, U., Cherry, R.C., Marshall, H.J. (2008), “Dangerous sandwiches.” Lancet 372(9656):2164.

22. Martin, U. (2008), “Hypertension guidelines: thresholds, targets and teratogenicity.” British Journal of General Practice. 58: 585.

23. Martin, U., Foreman, M., Travis, J., Carson, D., Coleman, J. (2008), “Angiotensin converting enzyme inhibitor use and angiotensin receptor blocker use in women of childbearing age.” Journal of Clinical Pharmacy and Therapeutics. 33:1-5.

24. Edwards, L., Ring, C., France, C., al’Absi, M., Martin, U., McIntyre, D., Carroll, D. (2008), “Effects of opioid blockade on nocioceptive flexion reflex thresholds and nocioceptive responding in hypertensives and normotensive individuals.” International Journal of Psychophysiology 69: 96-100.

25. Ring, C., France, C.R., al’Absi, M., Edwards, L., McIntyre, D., Carroll, D., Martin, U. (2008), “Effects of naltrexone on electrocutaneous pain in patients with hypertension compared to normal volunteers.” Biological Psychology  77:191-196.

26. Edwards, L., Ring, C., Winer, J., Martin, U. (2008), “Cutaneous sensibility and peripheral nerve function in patients with unmedicated essential hypertension.” Psychophysiology 45:141-147.

27. Tennant, R., Mohammed, M.A., Coleman, J.J., Martin, U. (2007), “A systematic review of the uses of statistical process control charts to monitor clinical variables in individual patients.” International Journal for Quality in Health Care 19:187-194.

28. Edwards, L., France, C.R., al'Absi, M., McIntyre, D., Ring, C., Carroll, D., Martin, U. (2007), “Psychomotor speed in hypertension: Effects of reaction time components, stimulus modality and phase of the cardiac cycle.” Psychophysiology 44:459-468..

29. Edwards, L., Ring, C., France, CR., al’Absi, M., McIntyre, D., Carroll, D., Martin, U. (2007), “Nocioceptive flexion reflex thresholds during performance of a cognitive task in patients with hypertension and individuals at risk for hypertension.” Biological Psychology 76:72-82.

30. Piper, M.K., Raza, K., Nuttall, S.L., Stevens, R., Toescu, V., Heaton, S., Gardner, Medwin. J., Hiller, L., Martin, U., Townend, J., Bacon, P.A., Gordon, C. (2007), “Impaired endothelial function in systemic lupus erythematosus.” Lupus 16:1-5.

31. Ring, C., France, C.R., al’Absi, M., Beesley, L., Edwards, L., McIntyre, D., Carroll, D., Martin, U. (2007), “Effects of opioid blockade with naltrexone and distraction on cold and ischemic pain in hypertension.” Journal of Behavioral Medicine 30:59-68.

32. Martin, U., Coleman, J.J. (2006), “Cases in primary care laboratory medicine. Testing pitfalls and summary of guidance in hypertension management.” British Medical Journal 333:896-899.

33. Edward, L., Ring, C., McIntyre, D., Carroll, D., Clarke, R., Webb, O., Martin, U. (2006), “Increases in arousal are associated with reductions in the human nocioceptive flexion threshold and pain ratings: Evidence for dissociation between nocioception and pain.” Journal of  Psychophysiology 20:259-266.

34. Peter. P., Martin, U., Sharma, A., Dunne, F. (2006), “Effect of treatment with nebivolol on parameters of oxidative stress in Type 2 diabetics with mild to moderate hypertension.”  Journal of Clinical Pharmacy and Therapeutics 31:153-159.

35. Martin, U., Hill, C., O’Mahoney, D. (2005), “Use of moxonidine in elderly patients with resistant hypertension.” Journal of Clinical Pharmacy and Therapeutics 30:433-437.

36. Langford, N.J., Landray, M., Martin, U., Kendall, M.J., Ferner, R.E. (2004), “Testing the practical aspects of therapeutics by objective structured clinical examination.” Journal of Clinical Pharmacy and Therapeutics 29:263-266.

37. Toescu, V., Nuttall, S.L., Martin, U. (2004), Nightingale, P., Kendall, M.J., Brydon, P., Dunne, F. (2004), “Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes.” Clinical Science 106:93-98.

38. Edwards, L., McIntyre, D., Carroll, D., Ring, C., France, C., Martin, U. (2003), “Effects of artificial and natural baroreceptor stimulation on nociceptive responding and pain.” Psychophysiology 40:762-769.

39. Nuttall, S.L., Heaton, S., Piper, M.K., Martin, U., Gordon, C. (2003), “Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia.” Rheumatology 42:758-762.

40. Langford, N.J., Krentz, A.J., Martin, U., Elliott, S., Ferner, R.E. (2003), “Severe relapsing sulphonylurea-induced hypoglycaemia: a diagnostic and therapeutic challenge.” Postgraduate Medical Journal 79:120-123.

41. Langford, NJ., Martin, U., Ruprah, M., Ferner, R.E.  (2002), “Alternative venlafaxine kinetics in overdose.”  Journal of Clinical Pharmacy and Therapeutics 27:465-467.

42. Toescu, V., Nuttall, S.L., Kendall, M.J., Martin, U., Dunne, F. (2002), “Women with gestational diabetes should be targeted to reduce cardiovascular risk.” British Medical Journal 7370:966.

43. Nuttall, S.L., Martin, U., Kendall, M.J., Dunne, F. (2002), “Short-term antioxidant supplementation reduces oxidative stress in elderly patients with type II diabetes mellitus.” Practical diabetes 19:199-202.

44. Toescu, V., Nuttall, S.L., Brydon, P., Kendall, M.J., Martin, U., Dunne, F. (2002), “Oxidative stress and normal pregnancy.” Clinical Endocrinology 57:609-613.

45. Edwards, L., McIntyre, D., Carroll, D., Ring, C., Martin, U. (2002), “The human nocioceptive flexion reflex threshold is higher during systole than diastole.” Psychophysiology 39:678-681.

46. Martin, U., Temple, R.M., Venkat-Raman, G., Prescott, L.F. (2002), “Paracetamol disposition in renal allograft recipients.” European Journal of Clinical Pharmacology 47:853-856.

47. Harper, L., Nuttall, S.L., Martin, U., Savage, C.O.S. (2002),  ”Adjuvant treatment of patients with ANCA-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils.” Rheumatology 41:274-278.

48. Langford, N., Martin, U., Kendall, M.J., Ferner, R.E. (2001), ”Medical schools can teach safe drug prescribing and administration.” British Medical Journal 322:1424.

49. Martin, U.  “Angiotensin converting enzyme inhibitors-induced angioedema.” British Journal of Cardiology 8:171.

50. Martin, U., Davies, C., Hayavi, S., Hartland, A., Dunne, F. (1999), “Is normal pregnancy atherogenic?” Clinical Science  96:421-425.

51. Nuttall, S.L., Dunne, F., Kendall, M.J., Martin, U. (1999), “Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus (NIDDM).” Quarterly Journal of Medicine 92:33-38.

52. Landray, M.J., Townend, J.N., Martin, U., Wheeler, D.  (1999), “Lipid-lowering drugs and homocysteine.” Lancet 353:1974-1975.

53. Landray, M.J., Nuttall, S.L., Lydakis, C., Martin, U., Maxwell, S.R.J., Lip, G.Y.H. (1998), ”Oxidative stress after thrombolysis.” Lancet 352:960.

54. Nuttall, S.L., Martin, U., Sinclair, A.J., Kendall, M.J.. “Glutathione: in sickness and in health.” Lancet 351:645-646.

55. Martin, U., Bryden, K., Devoy, M., Howarth, P. (1996), “Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis.” Journal of Allergy and Clinical Immunology 97:768-772.

56. Plant, W.D., Martin, U., Barron, W., Scouse, P.K., Winney, R.J., Prescott, L.F. (1995), “Absorption and clearance of ceftazidime during CAPD.” Peritoneal Dialysis International 15:378-382.

57. Martin, U., Winney, R.J., Prescott, L.F. (1995).  “Furosemide disposition in patients on CAPD.” European Journal of Clinical Pharmacology 48:385-390.

58. Howarth, P.H., Reddington, A.E., Springall, D.R., Martin, U., Bloom, S.R., Polak, J.M., Holgate, S.T.  (1995), “Epithelially derived endothelin and NO in asthma.” International Archives of Allergy and Immunology 107:228-230.

59. Rashid, T.J., Martin, U., Clarke, H., Waller, D.G., Renwick, A.G., George, C.F. (1995), “Factors affecting the absolute bioavailability of nifedipine.” British Journal of Clinical Pharmacology 40:51-58.

60. Pirmohamed, M., Martin, U. (1995), “Therapeutics 1995.” Journal of the Royal College of Physicians 29:530-534.

61. Martin, U., Prescott, L.F. (1994),  “The interaction of paracetamol with frusemide.” British Journal of Clinical Pharmacology 37:464-467.

62. Martin, U., Temple, RM., Winney, R.J., Prescott, L.F. (1993), “The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis.” European Journal of Clinical Pharmacology 43:141-5.

63. Garrigues, T.M., Martin, U., Peris‑Ribera, J.E., Prescott, L.F. (1991), “Dose‑dependent cefadroxil absorption and elimination in man.”  European Journal of Clinical Pharmacology 41:179‑183.

64. Martin, U., Temple, R.M., Winney, R.J., Prescott, L.F. (1991), “Cumulation of paracetamol and its metabolites during multiple dosing in patients with chronic renal failure.” European Journal of Clinical Pharmacology 41:43‑46.

65. Downey, D.B., Martin, U., Otridge, B., Ennis, T.J. (1989), “Thrombophlebitis as the presenting feature of extramedullary spread in multiple myeloma.” British Journal Clinical Practice 43:221‑223.

Book 

O’ Mahoney. D and  Martin, U. (1999), “Practical Therapeutics for the Older Patient.” John Wiley & Sons Ltd., Sussex U.K.

Book Chapters 

1. Coleman, J.J., Martin, U. (2007), “Antihypertensive Drugs.” In: Side Effects of Drugs Annual 29, Elsevier, Amsterdam. Netherlands, edited by Aronson, J.
2. Martin, U., Coleman, J.J. (2002, 2^nd edition 2007), “Pharmacovigilance and safety problems in the elderly.” In: Pharmacovigilance, John Wiley and Sons, Sussex U.K., edited by Mann, R.D., Andrews, E.
3. Martin, U., George, C.F. (1998), “Adverse drug reactions in the elderly.” In: Drug Therapy in Old Age, John Wiley & Sons, Sussex, UK, edited by George, C.F., Woodhouse, K., MacLennan, W., Denham, M.
4. Martin, U., Waller, D. (1994), “Chemotherapy of infection.” In: Principals of Medical Pharmacology, Balliere Tindall, London, UK., edited by Waller, D.G., Renwick, A.G.
5. Prescott, L.F., Martin, U. (1991), “Current status of nephrotoxicity caused by non‑steroidal anti‑inflammatory drugs.” In: Inflammation and Drug Therapy, Kluwer Academic Publishers, Lancaster U.K., edited by Rainsford, K.D., Velo, G.

Reviews

1. Pucci, M., Swareen, N., Knox E., Lipkin, G., Martin, U. “Angiotensin converting enzyme inhibitors in young women: risks vs benefits” (2015) Expert Review of Clinical Pharmacology 8:221-231. Doi:10.1586/17512433.2015.1005074
2. Hodgkinson, J.A., Tucker, K., Martin, U., Beesley, L., McManus, R.M., “The Use of Ambulatory Blood Pressure Measurement (ABPM)”. (2015) The British Journal of Hospital Medicine 76:631-635. doi:10.12968/hmed.2015.76.11.631  
3. Hodgkinson, J., Wood, S., Martin, U., McManus, R. “Blood pressure measurement-a practical guide for clinicians in primary care” (2014) British Medical Journal Learning http://learning.bmj.com/learning/module-intro/.html?moduleId=10047179&locale=en GB 
4. Hodgkinson, J.A., Wood, S., Martin, U., McManus, R.M. (2011).  “ABPM best for diagnosing hypertension in primary care.” The Practitioner.” 255 (1744):21-23.
5. Cotter, L.E., Martin, U. (2007), “Prescribing for older people.” Student British Medical Journal 15:372-373.
6. Branch, R.L., and Martin, U. (2006), “Adverse effects of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in pregnancy.” Adverse Drug Reaction Bulletin 240.
7. Coleman, J.J., Martin, U. (2006), “Drug-induced systemic hypertension.” Adverse Drug Reaction Bulletin 239, 2006.
8. Dunne, F., Kendall, M.J., Martin, U.(2001), “B-blockers in the management of hypertension in patients with type 2 diabetes mellitus. Is there a role?”  Drugs 61:429-435.
9. Nuttall, S.L., Kendall, M.J., Martin, U. (1999), ”Antioxidant therapy for the prevention of cardiovascular disease.” Quarterly Journal of Medicine 92:239-244.
10. Kendall, M.J., Nuttall, S.L., Martin, U. (1998), “Antioxidant therapy: a new therapeutic option for reducing mortality from coronary artery disease.” Journal of Clinical Pharmacy and Therapeutics 23:323-325.
11. Eagles, C., Martin, U. (1998), “Non pharmacological modification of cardiac risk factors-Part 3.” Journal of Clinical Pharmacy and Therapeutics 23:1-9.
12. Martin, U., Eagles, C. (1997), “Non pharmacological modification of cardiac risk factors-Part 2.” Journal of Clinical Pharmacy and Therapeutics 22:99-108.
13. Eagles, C., Martin, U. (1996), “Non pharmacological modification of cardiac risk factors-Part 1.”  Journal of Clinical Pharmacy and Therapeutics 21:289-296.
14. Martin, U., Waller, D. (1995), “Prodrugs.” Prescribers’ Journal 35:117-123
15. Martin, U., Waller, D. (1994). “Trial review: Acute Infarction Ramipril Efficacy (AIRE) Study.” British Journal of Cardiology 1:61-62
16. Martin, U., Waller, D. (1994), “ Selected side effects: Calcium antagonists and heart failure.” Prescribers’ Journal 34:157-160.

Learning modules

1. Martin U, Thomas S. Prescribing in Special Circumstances: Older Adults. SCRIPT eLearning programme. NHS Midlands and East (2011). Available on line at www.safeprescriber.org.